Krónikus vesebetegség: vizsgálatok itt: Puerto Rico
1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Humacao
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00